Fountain Therapeutics Is A Biotechnology Company Based In South San Franciscocaliforniaestablished In 2018The Company Focuses On Developing Innovative Therapies That Target Aging Associated Diseases Through Cellular Rejuvenationby Leveraging Expertise In Aging Biologycomputational Analysisand Drug Discoveryfountain Aims To Address Conditions Linked To Cellular Aging The Company Utilizes An Ai Driven Platform To Analyze Cellular Aging And Identify Drug Candidates That Can Reverse Cellular Agetheir Key Programs Include A Skin Atrophy Programwhich Features Topical Therapies Designed To Combat Age Related Skin Thinning And Weight Loss Induced Skin Saggingand A Muscle Atrophy Program That Targets Age Associated Sarcopenia And Lean Tissue Lossfountain Therapeutics Is Backed By Khosla Ventures And Is Advancing Its Preclinical Programs Toward Clinical Trialswith A Team Of Around 50 Employeesthe Company Is Positioned To Make Significant Contributions To The Longevity Therapeutics Sector
